Skip to main content

Find Clinical Trials

Home
Conditions
Respiratory Tract Neoplasms

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,109 public trials 1,857 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Not Yet Recruiting

Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)

NCT06102161

Conditions: Ground-glass Opacity, Lung Cancer, Lung Diseases, +7 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Not Yet Recruiting

Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib

NCT05988697

Conditions: Advanced Cancer, BRAF V600E Mutation, Bronchial Neoplasms, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer

NCT06067776

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Not Yet Recruiting

A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody

NCT06048315

Conditions: Anlotinib, EGFR Sensitive Mutation, Lung Cancer, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.

NCT06018688

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)

NCT05998993

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: CTIC - Centro de Tratamiento e Investigación Sobre Cáncer Luis Carlos Sarmiento Angulo Bogotá, Colombia

View Trial Details

Not Yet Recruiting

A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer

NCT05990127

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The first affiliated hospital of bengbu medical college Bengbu, Anhui, China

Anhui provincial hospital Hefei, Anhui, China

Anhui provincial cancer hospital Hefei, Anhui, China

The first affiliated hospital of wannan medical college Wuhu, Anhui, China

View all 62 locations

View Trial Details

Not Yet Recruiting

A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors

NCT05940116

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer

NCT05802654

Conditions: Early Lung Cancer, Lung Diseases, Lung Neoplasms, +6 more
Locations: Department of radiation oncology, Peking University Third Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

NCT05904015

Conditions: Lung Diseases, Lung Neoplasms, Neoplasms, +4 more
Locations: Not specified

View Trial Details